A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).
about
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or BFc-fusion technology and recombinant FVIII and FIX in the management of the hemophiliasPresent and future challenges in the treatment of haemophilia: the patient's perspectivePresent and future challanges in the treatment of haemophilia: a clinician's perspectiveTherapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia AIndividualized prophylaxis for optimizing hemophilia care: can we apply this to both developed and developing nations?The safety of pharmacologic options for the treatment of persons with hemophilia.Current and evolving features in the clinical management of haemophiliaUncovered needs in the management of inherited bleeding disorders in Italy.Is There Evidence for Neurocognitive Dysfunctions in Patients with Postnatal HIV Infection? A Review on the Cohort of Hemophilia PatientsUsing value-of-information methods when the disease is rare and the treatment is expensive--the example of hemophilia A.Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in ItalyRandomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors.Musculoskeletal evaluation in severe haemophilia A patients from Latin America.Outcome measures monitoring physical function in children with haemophilia: a systematic review.Humanistic and economic aspects of haemophilia treatment in Bulgaria. Comparison between two therapeutic approaches: prophylactic vs. on-demand treatmentAssociation of overweight and obesity with the use of self and home-based infusion therapy among haemophilic men.Issues in assessing products for the treatment of hemophilia - the intersection between efficacy, economics, and ethics.Persons with Haemophilia in Sweden- Experiences and Strategies in Everyday Life. A Single Centre StudyDiagnostic evaluation of our patients with hemophilia A: 17-year experienceAdherence to treatment regimen and bleeding rates in a prospective cohort of youth and young adults on low-dose daily prophylaxis for severe hemophilia A.A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A managementSustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVIIProphylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970sThe demand for factor VIII and for factor IX and the toll fractionation product surplus management.Clinical use of factor VIII and factor IX concentratesPredictors of quality of life among adolescents and young adults with a bleeding disorderHaemophilia: provision of factors and novel therapies: World Federation of Hemophilia goals and achievements.Joint protection in haemophilia.Exploring the biological basis of haemophilic joint disease: experimental studies.Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies.The literature on inhibitors: articles that influence my management of patients with hemophilia A and high-titer inhibitors.Haemophilia prophylaxis: how can we justify the costs?Octocog alfa, antihaemophilic factor (recombinant), plasma/albumin free method (Advate®): a review of its use in the management of patients with haemophilia A.Models of prophylaxis.Meeting the challenges of haemophilia care and patient support in China and Brazil.Management of joint bleeding in hemophilia.Factor VIII inhibitors in hemophilia A: rationale and latest evidenceInvestigational drugs for coagulation disorders.
P2860
Q24234413-20031830-EE05-43C1-A52B-8320A2068B1DQ27014771-54006061-E50A-4D67-B239-B2E1BCA01DEDQ27022801-14697AFC-698C-4F13-85F4-C2E372962C44Q27026137-BBC49A8E-C424-484D-B13A-2A1640B0D568Q28075081-50DDFFDD-FF12-464A-9DA4-02E92A56BF48Q28075208-F5F7854F-15BA-4497-9DC8-162318CC003CQ30249200-38174E37-982A-4521-B68D-97716643EF75Q33708976-EE5029C3-5575-4330-8CE0-F896A0C17F25Q33708980-95014911-03A4-4862-81A8-6B35C765A79DQ33794596-509BCAFD-2617-47FC-BB81-58E67C525DF4Q34011908-8F3621C3-CBFD-4788-883B-EF52147EEEB2Q34416394-024C3527-3D74-4047-86B5-79EECA7651CCQ34436796-2D297E5C-BD99-41E7-8876-F1A7F14905F2Q34844510-41AED12D-1BC3-4D49-9B3E-5FEAA2AFD401Q35046841-BFAE0C1F-0919-49F8-A6D7-71B689B662A7Q35613053-A6916170-C394-4533-B95A-C0907BED4C8EQ35741813-01851E0D-8284-4334-8A73-5DAC01250691Q35766551-C21FC3D2-EC4D-4541-B1CC-0A8F91454D4DQ35797283-71DE282C-922D-4909-8EBB-D03BEF6B52D9Q35913693-9C9D0969-48D5-4BA3-8852-140BA52EA93FQ36189452-C07F1926-1C67-40C5-ABD5-37E218283FB3Q36369011-4271A2BA-E71A-41E9-B5B7-61C909ED9F92Q36547796-DED23DC0-1938-49AC-AC78-064843F4B2A3Q36862474-5A9A2D2F-D4BA-4212-9E59-952B6BEBAB8EQ37098836-9279F0F5-8B9D-4C7A-868A-E5772830779AQ37370352-0CC409FF-8203-4715-86FE-9BEA31478716Q37370356-F70773C9-EF34-4937-BAF1-617610F0E816Q37740965-0C19499A-47FB-45B5-B2E9-68393592CCC9Q37894820-0DCE737A-0232-431F-A855-DBE5B2716AC9Q37912258-88348A9E-4ACB-42E3-A221-9F9BB0A96731Q37951686-A67EFFC8-B3B3-412D-949B-CEFE296C67D8Q37984127-397E20D0-A163-4E5E-B8DE-8B1304BE80C5Q37999694-BB398D9A-700D-4319-B049-3B7CBEDFDEEAQ38002994-2C4D21D3-586A-4013-A727-F14CFA347A0CQ38008021-42A8D525-348A-4EA2-94F1-790D727165CCQ38020979-B40FEC50-12D4-4A6F-93D8-596DEB1BDA8AQ38023505-B50D8490-3D48-492B-8571-F21EBBA3BEBEQ38044778-0115DE5C-D7F3-4AA7-90A7-6416E12A7A1FQ38101041-368A26F1-A53D-42A8-B8F3-414590C408C2Q38106245-0C2981C7-F02F-4ACC-A476-1DD8A7F0CB39
P2860
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
A randomized clinical trial of ...... mophilia A (the ESPRIT Study).
@en
A randomized clinical trial of prophylaxis in children with hemophilia A
@nl
type
label
A randomized clinical trial of ...... mophilia A (the ESPRIT Study).
@en
A randomized clinical trial of prophylaxis in children with hemophilia A
@nl
prefLabel
A randomized clinical trial of ...... mophilia A (the ESPRIT Study).
@en
A randomized clinical trial of prophylaxis in children with hemophilia A
@nl
P2093
P2860
P1476
A randomized clinical trial of ...... mophilia A (the ESPRIT Study).
@en
P2093
A Gringeri
ESPRIT Study Group
P M Mannucci
S von Mackensen
P2860
P304
P356
10.1111/J.1538-7836.2011.04214.X
P577
2011-04-01T00:00:00Z